Growth Metrics

CapsoVision (CV) Revenue (2024 - 2025)

CapsoVision recorded quarterly Revenue of $3.9 million in Q4 2025, up 10.74% quarter-over-quarter from $3.5 million in Q3 2025, and up 13.5% year-over-year from $3.5 million in Q4 2024.

CapsoVision's Revenue history runs 2 years deep, the most recent figure standing at $3.9 million for Q4 2025.

  • In Q4 2025, Revenue rose 13.5% year-over-year to $3.9 million; the TTM figure through Dec 2025 stood at $14.2 million (changed N/A YoY), while the FY2025 annual figure was $13.6 million, up 15.29% from the prior year.
  • Revenue came in at $3.9 million for Q4 2025 at CapsoVision, up from $3.5 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.9 million in Q4 2025 to a low of $2.8 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 11.16 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.02 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.02 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.65 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.57 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.19 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.59 Bn
10 CapsoVision 167.59 Mn 157.48 Mn 1.95 Mn 3.92 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.92 Mn
Sep 30, 2025 3.54 Mn
Jun 30, 2025 3.32 Mn
Dec 31, 2024 3.45 Mn
Sep 30, 2024 2.97 Mn
Jun 30, 2024 2.84 Mn